![]() | ![]() |
Formats:
|
||||||||||||||||||||||||
Copyright © 2008 Smith et al; licensee BioMed Central Ltd. The fungus Neurospora crassa displays telomeric silencing mediated by multiple sirtuins and by methylation of histone H3 lysine 9 1Institute of Molecular Biology and Department of Biology, University of Oregon, Eugene, OR 97403, USA 2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA Corresponding author.#Contributed equally. Kristina M Smith: smitkris/at/science.oregonstate.edu; Gregory O Kothe: gok1/at/psu.edu; Cindy B Matsen: cindy.matsen/at/hsc.utah.edu; Tamir K Khlafallah: tamir/at/molbio.uoregon.edu; Keyur K Adhvaryu: keyur/at/molbio.uoregon.edu; Melissa Hemphill: mahemphill/at/gmail.com; Michael Freitag: freitagm/at/cgrb.oregonstate.edu; Mohammad R Motamedi: mmotamedi/at/hms.harvard.edu; Eric U Selker: selker/at/uoregon.edu Received July 14, 2008; Accepted November 3, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Background Silencing of genes inserted near telomeres provides a model to investigate the function of heterochromatin. We initiated a study of telomeric silencing in Neurospora crassa, a fungus that sports DNA methylation, unlike most other organisms in which telomeric silencing has been characterized. Results The selectable marker, hph, was inserted at the subtelomere of Linkage Group VR in an nst-1 (neurospora sir two-1) mutant and was silenced when nst-1 function was restored. We show that NST-1 is an H4-specific histone deacetylase. A second marker, bar, tested at two other subtelomeres, was similarly sensitive to nst-1 function. Mutation of three additional SIR2 homologues, nst-2, nst-3 and nst-5, partially relieved silencing. Two genes showed stronger effects: dim-5, which encodes a histone H3 K9 methyltransferase and hpo, which encodes heterochromatin protein-1. Subtelomeres showed variable, but generally low, levels of DNA methylation. Elimination of DNA methylation caused partial derepression of one telomeric marker. Characterization of histone modifications at subtelomeric regions revealed H3 trimethyl-K9, H3 trimethyl-K27, and H4 trimethyl-K20 enrichment. These modifications were slightly reduced when telomeric silencing was compromised. In contrast, acetylation of histones H3 and H4 increased. Conclusion We demonstrate the presence of telomeric silencing in Neurospora and show a dependence on histone deacetylases and methylation of histone H3 lysine 9. Our studies also reveal silencing functions for DIM-5 and HP1 that appear independent of their role in de novo DNA methylation. Background Linear chromosomes pose a problem for replication of the terminal section of the DNA strand with a 5' end. The problem is solved in most eukaryotes by the addition of repeated sequences to the chromosome ends [1]. Thus the budding yeast Saccharomyces cerevisiae sports TG1–3 repeats on the ends of its chromosomes [2], while telomeres of both the filamentous fungus Neurospora crassa and humans comprise TTAGGG repeats [3,4]. Drosophila's chromosome ends are capped by arrays of retrotransposons and the adjacent subtelomeric DNA consists of repetitive elements called telomere-associated sequences (TAS) [4]. TAS appear cytologically condensed (that is, heterochromatic) [5] and confer silencing on nearby genes, apparently because of spreading of silent heterochromatin. This phenomenon, called 'telomeric silencing', or 'telomere position effect' (TPE), was initially discovered and studied using transgenes but it also appears to regulate endogenous subtelomeric genes [6-8]. Telomeric silencing has been demonstrated in organisms ranging from yeasts to humans (reviewed in [9]) but it has been best characterized in S. cerevisiae, Schizosaccharomyces pombe and Drosophila melanogaster, organisms that have no, or very little, DNA methylation. Heterochromatin at S. cerevisiae telomeres is nucleated by the telomere repeat binding protein Rap1 [10,11]. Telomeric silencing requires histone deacetylation by the conserved nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase (HDAC) Sir2p [12], reviewed in [13]. Sir2p is found in a complex with Sir4p, which interacts with Sir3p [14]. While Sir2p homologues (sirtuins) have been found in all eukaryotes examined, Sir3p and Sir4p are restricted to close relatives of S. cerevisiae. The fission yeast S. pombe lacks Sir3p and Sir4p but employs methylation of histone H3 lysine 9 (K9) plus a Sir2p homologue (Sir2) for silencing [15]. Deacetylation by Sir2 allows methylation of K9 by the Clr4 histone methyltransferase (HKMT), which in turn allows for binding by a homologue of Heterochromatin Protein-1 (HP1), Swi6 [15,16]. Swi6 is recruited to telomeres by interaction with the telomere repeat binding factor Taz1, which interacts with Rap1 and the RNAi-RITS complex [17]. The mechanism of telomeric silencing is largely unknown in plants and animals [1]. Silencing in Drosophila is dependent on telomere length, which depends on HP1 and its interaction with both telomere DNA and methylated H3 K9 [18-21]. One of the five Drosophila SIR2 homologues was tested for involvement in telomeric silencing but none was detected [22]. Sequences associated with mammalian telomeres show features of heterochromatin, including DNA methylation, trimethylated H4 K20, trimethylated H3 K9 and bound HP1, but the role of these factors remains to be elucidated [1]. Study of telomeric silencing in humans and mice has been limited, presumably in part because genes involved in heterochromatin formation and DNA methylation are essential in these organisms. We therefore initiated a study of telomeric silencing in N. crassa, which has DNA methylation like plants and mammals, but does not depend on it for survival. A single DNA methyltransferase (DNMT), DIM-2, is responsible for all known DNA methylation in Neurospora [23]. DNA methylation is directed by Neurospora's single HP1 homologue to chromosomal regions in which histone H3 is trimethylated at K9 by the HKMT DIM-5 [24-26]. DNA methylation in Neurospora is found predominantly at transposon relics [27], many of which are scattered throughout the genome but are most concentrated in centromeric and telomeric regions [28-30]. To look for TPE in Neurospora, we inserted transgenes near telomeres in mutants that were defective in candidate silencing genes and were thus predicted to relieve the telomeric silencing. We initially tested several putative sirtuins, which we named nst-1 (Neurospora sir two) through nst-7 [31]. We found evidence of TPE in Neurospora and found that several but not all of the nst genes are involved in silencing. We also tested the involvement of DIM-5, HP1 and DIM-2 to assess the potential influence of DNA methylation on TPE. Finally, we tested the effect of chemical inhibitors of HDACs and DNA methylation. We found evidence for the involvement of DIM-5, HP1 and HDACs in telomeric silencing in Neurospora. Interestingly, we found that the telomeric transgenes and native subtelomeric sequences are lightly methylated and that mutation of dim-2 can affect TPE, although not at all telomeres. We conclude that silencing by DNA methylation at non-telomeric chromosomal sites and silencing at telomeres share some components (DIM-5 and HP1) but represent distinct silencing pathways. Results Inactivation of nst genes To investigate whether Neurospora shows telomeric silencing, we needed to insert a genetic marker in a subtelomeric region and then test its expression in various genetic backgrounds. As the histone H4 K16-specific deacetylase Sir2p is central to telomeric silencing in previously examined eukaryotes and has also been implicated in other forms of silencing [9], we chose to test Neurospora homologues of Sir2p first. The Neurospora genome contains seven genes predicted to encode a protein with the NAD+-dependent deacetylase domain typical of the Sir2 family, the same number found in the human genome [32]. We designated these genes nst-1 (Neurospora sir two) through nst-7 [31]. NST-1 is most closely related to S. pombe Sir2p and S. cerevisiae Sir2p and Hst1p, two proteins that have partially redundant functions in telomeric silencing [12,33,34]. Neurospora also has close homologues of S. cerevisiae Hst3p (NST-4) and Hst4p (NST-3), which both act on acetylated K56 of histone H3 [35] and are required for telomeric silencing in yeast [33]. NST-2 is most closely related to S. cerevisiae Hst2p, which is cytosolic and disrupts telomeric silencing when over-expressed [36]. A tree based on a single alignment of the putative Sir2 catalytic domains of the Neurospora and human sirtuins (Sir2 homologues) is shown in Figure Figure1A.1A
We used RIP (repeat-induced point mutation) [38] to generate strains with nonsense mutations in nst-1. One such strain (N1982) served as the initial host for insertion of a telomeric reporter gene (see below). We also employed RIP to generate likely null alleles of several other nst genes; altogether, we identified strains with one or more stop codons in, or upstream of, the putative deacetylase domains of nst-1, -2, -3 and -5 (Figure (Figure1B).1B Silencing of hph at Telomere VR As a first step to test for telomeric silencing in Neurospora, we inserted a selectable marker, hph, into a subtelomeric region by homologous recombination in strain N1982, see figure figure2,2
We backcrossed the transformant with the desired insertion at Tel VR to an nst-1+ strain and found that hygromycin resistance (HygR) was lost in progeny with the nst-1+ allele, providing evidence for telomeric silencing in Neurospora and indicating that nst-1 plays a role in this process (Figure (Figure3A3A
To determine if more than one nst gene is required for telomeric silencing, we combined nst mutations described above with this hph marker and then tested the effect of the mutations on expression of hph at Tel VR. No loss of silencing was detected in spot tests with the nst-2 mutant (Figure (Figure3B)3B We also generated strains to test the possible effect on telomeric silencing of genes required for DNA methylation, namely dim-2, dim-5 and hpo, which respectively encode the DNMT responsible for all known methylation in Neurospora [23], the HKMT responsible of methylation of K9 on histone H3, and the adaptor protein HP1. Elimination of DNA methylation by mutation of dim-2 had no discernable effect on expression of hph at Tel VR (Figure (Figure3B).3B Silencing of bar at Telomere VIIL To determine whether telomeric silencing occurs at other Neurospora telomeres and works on other genes, we inserted the selectable markers bar, encoding Basta resistance, and ad-3A proximal to two other telomeres, namely those of chromosome arms VIIL and IIR (Figure (Figure2B2B The transformants with markers at VIIL and IIR were crossed to restore hpo function and test for silencing. We found that bar expression from the allele at Tel VIIL was lost in the hpo+ background (Figure (Figure3C).3C Having demonstrated telomeric silencing on two Neurospora chromosomes, we wished to test whether they showed a similar dependence on Sir2p homologues and other proteins implicated in heterochromatin formation. We therefore crossed strains bearing the marked Tel VIIL with strains bearing mutations in dim-2, dim-5, hpo, and the various nst genes that we found to be involved in telomeric silencing on chromosome V. Mutation of dim-5, hpo, nst-1, nst-2, nst-3 and nst-5 all caused loss of silencing of bar at Tel VIIL (Figure (Figure3C),3C Inhibitors of HDACs relieve telomeric silencing The HDAC Class I (Rpd3-like) and II (Hda1-like) inhibitor trichostatin A (TSA) [43] was previously shown to cause selective inhibition of DNA methylation in Neurospora [44]. To further explore the mechanism of telomeric silencing in Neurospora, we tested the effect of inhibitors of DNA methylation and HDACs on the expression of hph at Tel VR and bar at Tel VIIL. We first used a plating assay to test the effect of the Class III (sirtuin) HDAC inhibitor nicotinamide [45] on TPE and also on expression of an interstitial allele of hph allele that was silenced by DNA methylation spreading from flanking sequences that had been subjected to RIP [46]. Nicotinamide caused relief of hph at Tel VR but not at the interstitial site (Figure (Figure4A).4A
We adopted an assay involving a gradient of inhibitors for additional tests of the effects of nicotinamide, TSA and the DNA methylation inhibitor 5-azacytidine (5AC) on expression of the telomeric hph (Figure (Figure4B)4B NST activity The nst genes were identified by homology to SIR2. Not all Sir2p homologues appear to be HDACs; some have been shown to have non-histone substrates or lack deacetylase activity toward all substrates tested (reviewed in [13]). In one approach to determine whether the NST proteins have HDAC activity, we used western blotting to assess whether mutation of nst genes affected the global level of histone acetylation at candidate residues. Initial tests revealed no change in the nst-1, -3 or -5 mutants (data not shown), consistent with the possibility that they are partially redundant. We therefore tested a triple (nst-1 nst-3 nst-5) mutant and, indeed, found significant hyperacetylation (Figure (Figure5A)5A
To directly test whether at least one of the predicted NST proteins is an HDAC, we expressed NST-1 in Escherichia coli and assayed it for NAD+-dependent deacetylase activity with various acetylated histone peptides. NST-1 displayed robust activity with an H4 peptide acetylated on K16 and weak activity with an H3 peptide acetylated on K9, but showed no activity on H4 peptides acetylated on K5, K8, or K12 (Figure (Figure5B).5B
DNA methylation of subtelomeric regions Most available information on the structure and sequence of telomeres and subtelomeric heterochromatic regions is from organisms that do not have DNA methylation. Thus we were interested to examine both native and introduced sequences associated with telomeres for methylation in Neurospora. We found evidence of light DNA methylation at the silenced Tel VR hph marker and robust DNA methylation at the Tel VIIL bar marker (Figure (Figure7).7
To examine whether the telomeric methylation is dependent on HP1, as found for DNA methylation at other described chromosomal sites [26], we tested the effect of a null mutation of hpo. In addition, we tested the effect of mutating the three nst genes that we had found resulted in hyperacetylation of histones H3 and H4 (Figure (Figure5).5 Histone modifications associated with silent telomeric regions Little information is available about histone modifications in telomeric regions and no such information was available for Neurospora. We therefore used chromatin immunoprecipitation (ChIP) to characterize key modifications of histones H3 and H4 associated with sequences near Neurospora telomeres. Both marked and unmarked telomeres were examined because of the possibility that introduced markers could influence the epigenetic state of the chromatin. Results from our genetic studies with dim-5, hpo and nst mutants and from western blots suggested that the TAS would at least sport methylated K9 on H3 and would perhaps also show hypoacetylated histones. We found reproducible differences between telomeric regions and interstitial euchromatic regions (for example, histone H4 gene, hH4) and, interestingly, we also found differences between the telomeric regions and interstitial heterochromatic regions, that is, regions that had undergone RIP and whose DNA is methylated (8:F10). Like previously tested products of RIP bearing DNA methylation, the marked (hph; Figure Figure6A)6A The triple nst mutant attenuated the hypermethylation of H4 K20 and hypoacetylation of H3 and H4 at the marked telomere (note the ratio of telomeric to euchromatic PCR product normalized to the input DNA sample in Figure Figure6A).6A We also examined native Tel VIIL at the site where the bar gene was silenced and found comparable patterns of increased/decreased histone modifications, relative to control euchromatic sequences (data not shown). Interestingly, we also found hypoacetylation of H3 and H4 at all subtelomeric regions examined, including actively transcribed genes. The Tel IL and VIL primers amplify genes NCU10129.3 and NCU07143.3, respectively, both of which we found to be active genes. Northern analysis with RNA isolated from wild type and the triple nst strains showed that the expression of these genes, like their histone acetylation status, was comparable in the wild type and the triple nst mutant (Figure (Figure8)8
Discussion Structural similarities and differences between telomeres of Neurospora and other model organisms The structure of the currently known Neurospora telomere sequences [49] is quite simple. The length of Neurospora (TTAGGG)n repeats (~200 bp) is roughly ten-fold less than in mammals [29]. Unlike other fungi and mammals (reviewed in [50]), subtelomeric regions in Neurospora do not consist of tandem repeats and do not contain a particular class of repeat element present at each telomere, or even at a subset of the characterized telomeres. Rather, a short stretch of AT-rich DNA (roughly 2 kb long but variable in length) separates the first telomere repeat unit from the most telomere-proximal gene (Wu C, Kim YS, Smith KM, Li W, Hood HM, Staben C, Selker EU, Sachs MS, Farman ML, unpublished). The evolutionary origin of this telomere arrangement likely reflects the action of a genome defense system called RIP in Neurospora [38]. The RIP machinery detects duplicated sequences and changes C:G to T:A base pairs, presumably by deamination of cytosines or methylcytosines [51]. The resulting AT-rich sequences serve as targets for the DNA methyltransferase DIM-2 [23], which typically methylates remaining cytosines [52-54]. Subtelomeric sequences of Neurospora show hallmarks of RIP, namely a deficiency of CpA dinucleotides and a corresponding overabundance of TpA dinucleotides, the RIP machinery's preferred substrate and product, respectively [52], and DNA methylation (Tel VIIL; Figure Figure7).7 Telomeric markers for Neurospora The simple structure of Neurospora subtelomeres facilitated our strategy to insert selectable markers near Neurospora telomeres. For Tel VR, we chose to insert a copy of hph within a Pogo transposon relic found directly adjacent to the telomere repeat (Figure (Figure2A).2A Involvement of histone deacetylases in telomeric silencing The first evidence for telomeric silencing in Neurospora came from our observation of increased expression of the hph gene in a strain in which we had mutated nst-1, the closest homologue of S. cerevisiae SIR2. We then found evidence of extensive involvement of other deacetylases. The role of protein deacetylases, such as HDACs, is complex because of their multiple and partially overlapping functions. In S. pombe, telomeric silencing is dependent on deacetylation of histone H3 K9 and H4 K16 by Sir2, and subsequent methylation of histone H3 K9 [15,16]. A Sir2 deletion strain showed increased H3 K9 and H3 K14 acetylation at a subtelomeric region, and reduced H3 K9 methylation and Swi6/HP1 binding. Mutation of the Class I and II HDACs (Clr6 and Clr3, respectively) or treatment with the Class I/II HDAC inhibitor TSA also caused increased expression of telomere-linked genes [55,56]. In human cells, TSA, but not the sirtuin inhibitor sirtinol, caused derepression of a subtelomeric reporter and mislocalization of HP1 [57]. A recent study, however, showed SIRT6 is an H3 K9 deactylase that localizes to telomeres and is required for telomere integrity [58]. Little or no effect on subtelomeric gene expression was observed in mouse embryonic stem cells treated with TSA [59]. As such negative results of drug treatment assays are difficult to interpret, it remains possible that both Class I/II and III HDACs are required for mammalian telomere silencing; additional genetic studies may shed light on this. Our finding that NST-1 is a NAD-dependent (Class III) HDAC, as expected, fits our observation that nicotinamide is a potent inhibitor of telomeric silencing in Neurospora (Figure (Figure4).4 The finding that a triple nst mutant showed a greater increase in histone acetylation, as assayed by western blot of nuclear proteins and ChIP (Figures (Figures5A5A Trimethyl-K9 in histone H3 and HP1 are required for telomeric silencing in Neurospora We found that methylation of histone H3 K9, a mark produced by DIM-5 and required for DNA methylation [24,25], is required for telomere silencing (Figure (Figure3B3B DNA methylation is not generally required for silencing at Neurospora telomeres Mutation of the dim-2 gene, which is responsible for all known DNA methylation in Neurospora [23], did not cause loss of silencing of the hph gene targeted to Tel VR (Figure (Figure3B).3B In contrast to the situation at Tel VR, the sequences immediately proximal to Tel VIIL were significantly methylated (Figure (Figure7)7 In summary, our study on the structure and expression of sequences at Neurospora telomeres demonstrates the existence of telomeric silencing in Neurospora. We show important similarities, but also differences, in the silencing of markers integrated at subtelomeric regions. We also showed that at least one member of the Neurospora sirtuin family of NAD-dependent HDACs, NST-1, is a bona fide H4 K16 HDAC. Importantly, our work reveals an additional role for H3 K9 methylation and HP1 in Neurospora, independent of DNA methylation. It also provides evidence for the involvement of multiple classes of HDACs, including members of the NAD-dependent and -independent classes, and H3 K27 and H4 K20 HMTs. One major question remaining is how exactly heterochromatin is nucleated at Neurospora subtelomeres, as the Neurospora genome contains no good homologues of S. pombe Taz1 or mammalian telomere repeat binding factors. Methods Neurospora strains and growth conditions A list of N. crassa strains used in this study is provided in Table 1[62,63]. Standard conditions were used for their growth and maintenance [64].
Protein sequences Accession numbers for protein sequences in Figure Figure11 Mutagenesis by RIP The nst-1 gene was amplified from genomic DNA with primers nst-1-1 and nst-1-2 (all primer sequences are listed in Table 2). The BamHI+XbaI-digested PCR product was cloned into the BamHI+XbaI-digested his-3 targeting vector pBM61 [65], generating pBM61-Sir2. pBM61-Sir2 was linearized with NdeI and targeted to the his-3 locus in strain N1674 by electroporation [65]. A his-3+::nst-1 transformant was crossed to strain N593 and random progeny was analyzed for evidence of RIP by Southern blotting. The endogenous nst-1 locus from one strain (N2225) showed RsaI RFLPs and was sequenced to identify the RIP mutations.
The nst-2 gene was amplified from genomic DNA with primers S2L1-EcoRI and S2L1-SpeI, digested with EcoRI+SpeI, and cloned into EcoRI+SpeI-digested pBM61. The resulting plasmid, pBM61-S2L1, was linearized with NdeI and targeted to his-3 in strains N1445 and N1674. To mutate nst-3, the gene was amplified with primers S2L2-EcoRI and S2L2-Not1, digested with EcoRI+NotI, and cloned into EcoRI+NotI-digested pBM61. The resulting plasmid, pBM61-S2L2, was linearized with NdeI and targeted his-3 in strains N1445 and N1674. For both nst-2 and nst-3, His+ transformants of N1445 and N1674 were crossed to each other and progeny were analyzed for evidence of RIP by Southern blotting of RsaI-digested DNA; RIP mutated alleles were then sequenced. The nst-5 gene was amplified with primers 203-4 and 203-5, digested with BamHI+PacI and inserted into BamHI+PacI-digested pMF272 [66]. The resulting plasmid, pKA13, was linearized with DraI and targeted to his-3 in strain N1674. A His+ transformant was crossed to strain N1447 and two progeny with duplications were then crossed to induce RIP. Southern analysis revealed RFLPs in strain N2681; thus the endogenous allele was sequenced. Insertion of markers at telomeres The bacterial hph gene under the control of the constitutive trpC promoter was removed from pCSN43 [67] by digestion with SalI and ligated to XhoI-digested pGRG-1/TYR103 [68] to generate pCM8. To generate pCM11, pCM8 was digested with PvuII and the hph fragment was ligated to HpaI-digested pNC36 [3], which contains the Pogo transposon from the subtelomere of linkage group VR. BsiWI-digested pCM11 was used to transform strain N1982 (derived from a cross between strains N2225 and N565, which was derived from a cross between strains N564 and N534). Correct integration at LG VR was confirmed by Southern blotting in the transformant, N2292, and this strain was backcrossed to strain N534 and WT (N2285). We identified nst-1RIP1 progeny that retained telVR::hph::T for further study (strains N2284, N2288). A Southern blot demonstrating subtelomeric integration is shown in Figure Figure3.3 The ad-3A coding region with its promoter was amplified from genomic DNA with primers ad-3AF and ad-3AR. To generate pTTK17, the ad-3A PCR product was digested with NotI+BamHI and ligated to pBARKS1 [69] digested with the same enzymes. Plasmid pBARKS1 contains the bar gene under the control of the trpC promoter, which allows selection for glufosinate ('Basta') resistance. A region near Tel VIIL (324–1306 bp from the chromosome end) was amplified by PCR with primers Tel7L5FAatII and Tel7L5RPmlI, digested with PmlI+AatII and ligated to pTTK17 DNA that had been digested with the same enzymes, yielding plasmid pTTK18. A second region of Tel VIIL (1310–2319 bp from the chromosome end) was amplified with primers Tel7L3FBamHI and Tel7L3REcoRI, digested with BamHI+EcoRI and ligated to pTTK18 digested with the same enzymes, yielding the gene targeting vector pTTK19. AlwNI-linearized pTTK19 was transformed into N3017 and BastaR colonies were selected. Following confirmation of correct insertion by PCR analysis and Southern blotting (Figure (Figure3),3 The same ad-3A bar construct was also targeted to the subtelomeric region of Tel IIR. A region near Tel IIR (1444–2472 bp from the chromosome end) was amplified with primers Tel2R3FBam and Tel2R3REco, digested with BamHI+EcoRI and ligated to pBARKS1 [69] digested with the same enzymes, yielding plasmid pTTK20. The ad-3A region was amplified and inserted into pTTK20 as described above, yielding pTTK21. A second region of Tel IIR (259–1278 bp from the chromosome end) was amplified with primers Tel2R5FAatII and Tel2R5RPmlI, digested with AatII+PmlI and ligated to pTTK21 DNA digested with the same enzymes, yielding gene targeting vector pTTK22. AlwNI-linearized pTTK22 was transformed into N3017 and BastaR colonies were selected. Following confirmation of correct insertion by PCR analysis and Southern blotting (Figure (Figure3),3 Telomeric silencing assay Conidia from strain N3120 (telVR::hph+) or N3441 (tel VIIL::bar+) were collected in water from flasks containing Vogel's minimal medium, 2% sucrose, 1.5% agar and appropriate supplements after 1 week of growth at 32°C. Roughly 1000 conidia were spread on Vogel's minimal agar plates with 2% sorbose, 0.05% fructose and 0.05% glucose (FGS) and allowed to dry briefly. Nicotinamide was included in agar medium at 1 mg/ml. For the other drugs, 2 mm × 2 mm filter paper squares soaked with 0.5 μl 5-aza-cytidine (Sigma; 24 mM in H2O) or 2 μl Trichostatin A (Wako; 33 mM in DMSO) were placed in the center of the plate. After 5 hr at 32°C, 5 ml 0.7% top agar with 3 mg/ml Hygromycin B (Hyg; Hygrogold, InvivoGen) was overlaid for a final concentration of 0.5 mg/ml. For Basta selection, Vogel's salt solution with low nitrogen was used in all media [39]. For better imaging of smaller colonies on Basta selection plates we avoided top agar and instead 20 mg/ml Basta isolated from Rely (Bayer) [70] was poured in 5 ml of bottom agar, then 20 ml of non-selective media was overlaid for a final concentration of 4 mg/ml Basta. Plates were photographed after an additional 2 days of incubation at room temperature. To assay the effect of nicotinamide on expression of hph located at a telomere or at an interstitial location flanked by amRIP sequences, nicotinamide and Hyg were both added directly to agar medium and roughly 105 conidia were spread. Photographs were taken after 2 days of incubation at 32°C. Spot tests of mutants To assay Hyg resistance, conidia were collected in water from flasks containing Vogel's minimal medium, 2% sucrose, 1.5% agar plus supplements following 1 week of growth at 32°C. Conidial suspensions were counted in a hemocytometer and serial dilutions were plated on Vogel's FGS agar medium with the same supplements, in the presence or absence of 1 mg/ml Hyg. Strains were allowed to grow for 2 days at 32°C. To test Basta resistance [39], conidia were prepared as above and plated on supplemented Vogel's FGS media prepared with low nitrogen and 1.5% agar in the presence or absence of 2 mg/ml Basta. Southern blots Western blots Nuclei were isolated as described [71] with the addition of HDAC inhibitors, TSA (1 μM, Wako) and sodium butyrate (50 mM, J.T. Baker). Nuclear proteins were fractionated by 10% SDS-PAGE. Following transfer to PVDF membrane (Millipore Immobilon-P) in 10 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), pH 11 with 20% methanol, blots were probed in phosphate-buffered saline (PBS) plus 3% non-fat dry milk with the following antibodies diluted as recommended by the manufacturer: α-H3 (Abcam ab1791), α-H3 acetyl K9 (Abcam ab4441), α-H3 acetyl K14 (Upstate 06–911), α-H3 acetyl K9/K14 (Upstate 06–599), α-H4 tetra-acetyl (Upstate 06–866) and α-H4 acetyl K16 (Upstate 07–329). Antibody detection was performed as described [25]. Histone deacetylase assays NST-1 was expressed as a GST fusion protein for in vitro activity assays. The nst-1 coding region was amplified with primers Nst1BamHI and Nst1NotI, digested with BamHI+NotI and cloned into BamHI+NotI-digested pGEX-5X-2 (GE Healthcare). The protein was expressed in E. coli strain BL21, induced with IPTG and purified on glutathione agarose (Sigma) in RIPA buffer (20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 mM DTT). Following elution with reduced glutathione, the GST fusion protein was dialyzed against RIPA buffer with 25% glycerol. In vitro activity assays were performed as described [15]. Chromatin immunoprecipitation ChIP experiments were performed as described [25] with the antibodies above and with α-H3 trimethyl K9 [72], α-H3 trimethyl K27 (Upstate 07–449), and α-H4 trimethyl K20 (Upstate 07–463). Primers used for the detection of precipitated DNA fragments are listed in Table 2. PCR reactions were repeated at least two times for each of two independent ChIP experiments. Competing interests The authors declare that they have no competing interests. Authors' contributions KMS helped design the study, generated strains, performed silencing assays, spot tests, Western blots, southern blots, northern blots, ChIP assays, sequence alignments and drafted and revised the manuscript. GOK helped design the study, created nst mutants, performed silencing assays, and revised the manuscript. CBM helped conceive of and design the study and generated nst-1 and telomere targeted marker strains. TKK generated strains and performed Southern blots. KKA generated the nst-5 mutant. MH helped generate nst mutants. MF helped conceive of and design the study and revised the manuscript. MRM performed the in vitro deacetylase assays. EUS conceived of and helped design the study, and revised the manuscript. All authors gave final approval of the manuscript. Acknowledgements We thank Jon Murphy, Adam Caccavano, and Jeewong Choi for technical assistance and Eric Gilson for comments on the manuscript. This work was supported by grants from the National Institutes of Health (GM025690-22 to EUS; GM61641 to Danesh Moazed) the National Science Foundation (MCB-0121383 to EUS), an American Cancer Society postdoctoral fellowship to KMS (PF-04-043-01-GMC), a Canadian Institute of Health Research postdoctoral fellowship to MRM and an American Cancer Society grant (RSG-08-030-01-CCG to M.F). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||
Nat Rev Genet. 2007 Apr; 8(4):299-309.
[Nat Rev Genet. 2007]Nature. 1984 Jul 12-18; 310(5973):157-60.
[Nature. 1984]Mol Cell Biol. 1987 Sep; 7(9):3168-77.
[Mol Cell Biol. 1987]Trends Genet. 1995 Feb; 11(2):58-62.
[Trends Genet. 1995]Annu Rev Genet. 1995; 29():577-605.
[Annu Rev Genet. 1995]Cell Mol Life Sci. 2003 Nov; 60(11):2303-18.
[Cell Mol Life Sci. 2003]Genes Dev. 1994 Oct 1; 8(19):2257-69.
[Genes Dev. 1994]J Cell Biol. 1995 May; 129(4):909-24.
[J Cell Biol. 1995]Nature. 2000 Feb 17; 403(6771):795-800.
[Nature. 2000]Annu Rev Biochem. 2004; 73():417-35.
[Annu Rev Biochem. 2004]Nat Rev Genet. 2007 Apr; 8(4):299-309.
[Nat Rev Genet. 2007]Genetica. 2003 Mar; 117(2-3):319-25.
[Genetica. 2003]Curr Opin Genet Dev. 2008 Apr; 18(2):169-74.
[Curr Opin Genet Dev. 2008]Cell. 2002 May 17; 109(4):447-58.
[Cell. 2002]EMBO J. 2001 Aug 1; 20(15):4309-23.
[EMBO J. 2001]Nature. 2001 Nov 15; 414(6861):277-83.
[Nature. 2001]Mol Cell. 2004 Feb 13; 13(3):427-34.
[Mol Cell. 2004]Nature. 2003 Apr 24; 422(6934):893-7.
[Nature. 2003]Mol Cell Biol. 1998 Sep; 18(9):5465-77.
[Mol Cell Biol. 1998]Microbiol Mol Biol Rev. 2004 Mar; 68(1):1-108.
[Microbiol Mol Biol Rev. 2004]Cell Mol Life Sci. 2003 Nov; 60(11):2303-18.
[Cell Mol Life Sci. 2003]Mol Biol Cell. 2005 Oct; 16(10):4623-35.
[Mol Biol Cell. 2005]Microbiol Mol Biol Rev. 2004 Mar; 68(1):1-108.
[Microbiol Mol Biol Rev. 2004]Nature. 2000 Feb 17; 403(6771):795-800.
[Nature. 2000]Genes Dev. 1995 Dec 1; 9(23):2888-902.
[Genes Dev. 1995]Adv Genet. 2002; 46():439-50.
[Adv Genet. 2002]Genes Dev. 1995 Dec 1; 9(23):2888-902.
[Genes Dev. 1995]Mol Cell Biol. 1987 Sep; 7(9):3168-77.
[Mol Cell Biol. 1987]Gene. 1990 Apr 16; 88(2):159-65.
[Gene. 1990]Gene. 1990 Apr 16; 88(2):159-65.
[Gene. 1990]EMBO J. 2001 Aug 1; 20(15):4309-23.
[EMBO J. 2001]Proc Natl Acad Sci U S A. 2004 Aug 17; 101(33):12248-53.
[Proc Natl Acad Sci U S A. 2004]Annu Rev Genet. 2006; 40():237-77.
[Annu Rev Genet. 2006]EMBO J. 2001 Jan 15; 20(1-2):210-21.
[EMBO J. 2001]J Biol Chem. 1990 Oct 5; 265(28):17174-9.
[J Biol Chem. 1990]Proc Natl Acad Sci U S A. 1998 Aug 4; 95(16):9430-5.
[Proc Natl Acad Sci U S A. 1998]J Biol Chem. 2002 Nov 22; 277(47):45099-107.
[J Biol Chem. 2002]Genetics. 1997 Jun; 146(2):509-23.
[Genetics. 1997]Annu Rev Biochem. 2004; 73():417-35.
[Annu Rev Biochem. 2004]Nature. 2003 Apr 24; 422(6934):893-7.
[Nature. 2003]Mol Cell. 2004 Feb 13; 13(3):427-34.
[Mol Cell. 2004]Nature. 2003 Apr 24; 422(6934):893-7.
[Nature. 2003]Genes Dev. 1997 Sep 15; 11(18):2383-95.
[Genes Dev. 1997]Genes Dev. 1997 Sep 15; 11(18):2383-95.
[Genes Dev. 1997]Gene. 1990 Apr 16; 88(2):159-65.
[Gene. 1990]Curr Opin Genet Dev. 1997 Dec; 7(6):822-8.
[Curr Opin Genet Dev. 1997]Adv Genet. 2002; 46():439-50.
[Adv Genet. 2002]Trends Biochem Sci. 1990 Mar; 15(3):103-7.
[Trends Biochem Sci. 1990]EMBO J. 2001 Aug 1; 20(15):4309-23.
[EMBO J. 2001]Curr Biol. 2003 Jul 15; 13(14):1240-6.
[Curr Biol. 2003]Genetics. 2005 Mar; 169(3):1243-60.
[Genetics. 2005]Mol Cell Biol. 2005 Jan; 25(2):590-601.
[Mol Cell Biol. 2005]Nucleic Acids Res. 2006; 34(1):78-88.
[Nucleic Acids Res. 2006]EMBO Rep. 2002 Nov; 3(11):1055-61.
[EMBO Rep. 2002]Microbiol Mol Biol Rev. 2004 Mar; 68(1):1-108.
[Microbiol Mol Biol Rev. 2004]EMBO J. 2001 Jan 15; 20(1-2):197-209.
[EMBO J. 2001]Mol Biol Cell. 2005 Oct; 16(10):4623-35.
[Mol Biol Cell. 2005]Nature. 2001 Nov 15; 414(6861):277-83.
[Nature. 2001]Nat Genet. 2003 May; 34(1):75-9.
[Nat Genet. 2003]Mol Cell. 2004 Feb 13; 13(3):427-34.
[Mol Cell. 2004]EMBO J. 2001 Aug 1; 20(15):4309-23.
[EMBO J. 2001]EMBO Rep. 2002 Nov; 3(11):1055-61.
[EMBO Rep. 2002]Mol Cell Biol. 2006 Mar; 26(5):1865-78.
[Mol Cell Biol. 2006]Nat Rev Genet. 2007 Apr; 8(4):299-309.
[Nat Rev Genet. 2007]Nat Genet. 2004 Jan; 36(1):94-9.
[Nat Genet. 2004]Hum Mol Genet. 2003 Jun 1; 12(11):1329-36.
[Hum Mol Genet. 2003]Genetics. 1994 Dec; 138(4):1093-103.
[Genetics. 1994]Genetics. 2002 Mar; 160(3):961-73.
[Genetics. 2002]Fungal Genet Biol. 2004 Oct; 41(10):897-910.
[Fungal Genet Biol. 2004]Mol Cell Biol. 1987 Sep; 7(9):3168-77.
[Mol Cell Biol. 1987]J Mol Biol. 2000 Jul 7; 300(2):249-73.
[J Mol Biol. 2000]Proc Natl Acad Sci U S A. 1986 Sep; 83(17):6533-7.
[Proc Natl Acad Sci U S A. 1986]Nat Genet. 2003 May; 34(1):75-9.
[Nat Genet. 2003]Curr Biol. 2003 Jul 15; 13(14):1240-6.
[Curr Biol. 2003]Nat Genet. 2003 May; 34(1):75-9.
[Nat Genet. 2003]Chromosoma. 2002 Mar; 111(1):22-36.
[Chromosoma. 2002]